4.5K Views 3 years ago

Why Larger Animals Don’t Get More Cancer

Cancer, an intricate interplay of genetic mutations and cellular growth gone awry, has long perplexed scientists and medical researchers alike. The prevalence of cancer varies significantly among species, and intriguingly, some of the largest and longest-living creatures on Earth, like elephants and whales, seem to defy the odds by exhibiting lower rates of cancer despite having exponentially more cells than humans. This phenomenon, known as Peto’s Paradox, has captured the attention of researchers seeking to unravel the mysteries of cancer prevention and management.

Source: Be Smart/YouTube

In an episode of the Science Show, hosted by Robyn Williams, Dr. Carlo Maley, a professor at the Center for Evolution and Medicine at Arizona State University, delves into the intricacies of Peto’s Paradox and its potential implications for understanding and treating cancer.

The heart of Peto’s Paradox revolves around the contradiction between the number of cells in an organism and its cancer susceptibility. As Dr. Maley explains, each cell in the body carries a certain probability of undergoing a cancerous transformation. Logically, larger animals with more cells should face a higher risk of cancer. For example, an elephant, boasting a whopping 100 times more cells than a human, should theoretically be overrun by cancer. However, this isn’t the case.

Dr. Maley offers a compelling perspective on the evolutionary forces at play in addressing Peto’s Paradox. He suggests that larger, long-lived animals like elephants and whales have experienced significant natural selection pressures that favored the development of effective cancer prevention mechanisms. Animals that succumbed to cancer at an early age before reproducing failed to pass on their genetic material, diminishing the likelihood of cancer-prone traits being perpetuated in the population.

Drawing a fascinating analogy, Dr. Maley likens this process to an engineering concept. Much like how an engineer would focus on enhancing components that wear out quickly in a system, natural selection concentrates on fortifying aspects critical to an organism’s survival. For instance, if cancer posed a significant threat to elephants, their success would hinge on developing potent defenses against it. Conversely, smaller, short-lived organisms like mice might not experience the same intensity of natural selection for robust cancer prevention.

To crack the enigma of Peto’s Paradox, Dr. Maley and his colleagues embarked on a mission to identify and study species that exhibit exceptional resistance to cancer. Their efforts expanded the list of species with known cancer rates from a mere handful to over 300. This extensive dataset enables researchers to explore patterns and pinpoint factors that influence an organism’s susceptibility to cancer.

One intriguing revelation involves the role of tumor suppressor genes, specifically the P53 gene. Elephants, for instance, possess 20 copies of the P53 gene compared to humans’ single copy. This gene serves as a sentinel, detecting DNA damage within cells. When damage becomes excessive, P53 initiates a self-destruct mechanism called apoptosis, eliminating the compromised cell. In elephants, exposure to even slight levels of radiation triggers rapid cell death, minimizing the risk of mutations that can lead to cancer.

The insights gleaned from studying animals that defy Peto’s Paradox offer hope for revolutionizing cancer prevention and treatment strategies in humans. Dr. Maley envisions a future where cancer becomes a manageable chronic condition rather than an insurmountable foe. Drawing inspiration from agricultural pest management, which focuses on controlling rather than eradicating pests, the same philosophy could be applied to cancer. Instead of striving for a complete cure, scientists might work toward effectively controlling cancer and maintaining patients’ quality of life.

Sign this petition to help raise awareness and funding for curing childhood cancer.